It's where Ada gets its news!
January 19, 2021

You are here

Health Services

Kidney stone prevention

Everything you need to know about kidney stones

This column is provided by ONU HealthWise Pharmacy.

Kidney stones may be small, but they can pack a lot of pain. Read on to find out how you can reduce your chance of developing kidney stones.

Kidney stones form in the kidneys and can cause discomfort and pain. They can be small, but large ones can become stuck in the urinary tract, blocking the flow of urine and causing intense pain.

In some cases, kidney stones will pass on their own. However, in other situations, medical treatment may be necessary. The following are signs of kidney stones that require a doctor's attention:

Extreme pain in your back or side (Pain tends to remain and not go away.)

Multi-condition nasal spray recalled

Manufacturers of desmopressin nasal spray recalls all lots

This column is provided by Ohio Northern University HealthWise Pharmacy.

All lots of Ferring Pharmaceuticals' multi-condition nasal spray are being recalled.

The problem? These lots have higher-than-specified amounts of desmopressin.

Higher amounts of desmopressin can lead to abnormally low levels of sodium in the blood. And very low levels of sodium in the blood can lead to dangerous health events, such as seizures, coma and even death.

Nasal spray for depression gets new approved use

FDA approves Spravato (esketamine) to treat major depressive disorder

This column provided by ONU HealthWise Pharmacy.
Spravato (esketamine) is considered the first big advancement in depression treatment since the approval of Prozac — and it just got approved for a new use.

Approved for treatment-resistant depression (TRD) in March of 2019, esketamine is now approved to treat depressive symptoms in adults with major depressive disorder (MDD) and acute suicidal ideation or behavior.

New COVID-19 test gets green light

FDA approves first COVID-19 test for those without symptoms

This column is provided by the ONU HealthWise Pharmacy.

The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a new COVID-19 diagnostic test that can test people who are not showing symptoms.

This test is found under the name LabCorp COVID-19 RT-PCR.

This test was originally given an EUA in early March. It was to test those whose health care providers suspected that they might have COVID-19, and it only tested individual specimens (no sample pooling). But that changed with this new EUA from the FDA.

Now, this diagnostic option can be used for two new things:

Ask Me Anything about covid-19

Ross Kauffman answers "Are confirmed cases inflated due to repeated tests of the same positive individual?"

This is the first in a series of brief YouTube videos focusing on covid-19. This video is part of Ada SAFE 2020 AMA (ask me anything) question series.

Ross Kauffman, assistant professor and director of public health at Ohio Northern University, speaks to the question: "Are confirmed cases inflated due to the repeated tests of the same positive individual?"

Click here to learn more about this series and to visit the online site that provides resources about the virus.

COVID-19 and flu test combined

FDA approves test that can detect both COVID-19 and flu

This column is provided by ONU HeathWise Pharmacy.
 The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a third combination test for COVID-19 and the flu.

This new test is found under the name Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay.

The FDA previously issued EUAs to BioFire Diagnostics LLC and QIAGEN GmbH for their combination tests. These particular combination tests can help identify other respiratory organisms in addition to the viruses that cause the flu and COVID-19.